FOERFARANDE FOER FRAMSTAELLNING AV EN FARMACEUTISK HARTSKOMPOSITION MED KONTROLLERAD FOERDROEJD FRIGIVNING AV DEXTROMETORFANHYDROBROMID
The invention relates to a pharmaceutical preparation for controlled, sustained release of dextromethorphan comprising a polystyrene sulfonate resin which has been crosslinked with about 3% to about 10% divinyl benzene, having an average particle size of at least 40 mu m and less than 100 mu m onto...
Gespeichert in:
Hauptverfasser: | , |
---|---|
Format: | Patent |
Sprache: | fin |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention relates to a pharmaceutical preparation for controlled, sustained release of dextromethorphan comprising a polystyrene sulfonate resin which has been crosslinked with about 3% to about 10% divinyl benzene, having an average particle size of at least 40 mu m and less than 100 mu m onto which dextromethorphan has been loaded in a ratio expressed in weight amounts of dextromethorphan-hydrobromide to resin of about 1:6 to about 1:10 and at least one pharmaceutically acceptable adjuvant. |
---|